Guangzhou Biotron Technology Co.,Ltd

Biotron was founded in 2012. It is located in the Enterprise Accelerator with beautiful scenery and abundant human resources in Guangzhou.Aim individualized molecular target detection and immune detection as the core, and has become a high-tech enterprise integrating the development, production and sales of IVD instruments and reagents.Headquartered in Guangzhou, Biotron has set up R&D centers and production bases in a number of countries and regions including English,Japan,Shenzhen, Zhuhai,Hunan and Wuhan. Currently, the company has nearly 130 employees.

The company covers an area of nearly 6600 ㎡ in Guangzhou and 60000㎡ factory building in Zhuhai, including R & D and manufacturing base.

After 10 years of precipitation and accumulation, the R&D team has built a clinical examination product platform, POCT platform, molecular diagnostic platform, microfluidic platform and immunohistochemistry platform. Focusing on POCT detection, molecular biological diagnosis, prenatal and postnatal care, individualized tumor detection, rapid pathogen detection, drug resistance mutation detection, immunohistochemistry and other fields. More than 70 technical patents have been applied for, The full line of products has been installed or served many domestic medical devices unit. In 2020,Guangdong RAS Medical Technology Co., Ltd was also established which is a one-step medical device service platform of CDMO+CRO+CSO.

Inspired by its corporate vision –“Care for life, Focus on medical” and always be customer-oriented, focus on innovation, pursue excellence, continuously improve corporate competitiveness, and commit to providing high-quality in vitro diagnostic products.